Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion type Assertion NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_head.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion description "[Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_provenance.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion evidence source_evidence_literature NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_provenance.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion SIO_000772 10482985 NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_provenance.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion wasDerivedFrom befree-20140225 NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_provenance.
- NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_assertion wasGeneratedBy ECO_0000203 NP399097.RAIm6WE0jRyKAes_v5QlN6CeNK-WMQKzc08FPDBA4oADY130_provenance.